---
title: "Zhejiang Medicine plans to spend 100 million to 200 million yuan to repurchase shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/235831141.md"
description: "According to the Zhitong Finance APP, ZMC has announced a share repurchase plan. The total amount of funds for this share repurchase will not be less than RMB 100 million (inclusive) and will not exceed RMB 200 million (inclusive). The repurchase price will not exceed RMB 20.83 per share (inclusive), and the repurchased shares will be used for the employee stock ownership plan or equity incentives"
datetime: "2025-04-14T09:20:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/235831141.md)
  - [en](https://longbridge.com/en/news/235831141.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/235831141.md)
generator: "portal-rs"
---

# Zhejiang Medicine plans to spend 100 million to 200 million yuan to repurchase shares

According to the Zhitong Finance APP, Zhejiang Medicine (600216.SH) has announced a share repurchase plan. The total amount of funds for this repurchase will not be less than RMB 100 million (inclusive) and not exceed RMB 200 million (inclusive). The repurchase price will not exceed RMB 20.83 per share (inclusive), and the repurchased shares will be used for the employee stock ownership plan or equity incentives

### Related Stocks

- [600216.CN](https://longbridge.com/en/quote/600216.CN.md)

## Related News & Research

- [Bessent's bond gambit aimed at calming markets is instead stirring inflation worries](https://longbridge.com/en/news/296642975.md)
- [Trump’s Bond Buyback Push Puts Kevin Warsh in a Tough Spot — Peter Schiff Says Treasury ‘Pulled the Rug Out From Under’](https://longbridge.com/en/news/296615127.md)
- [The rise in interest rates hit a 'raw nerve' at the White House. Bessent's plan has analysts on edge.](https://longbridge.com/en/news/296517751.md)
- [Oura exploring how its ring could detect brain hemorrhages after Bill Ackman suggests it could have helped his daughter](https://longbridge.com/en/news/296658401.md)
- [HENGRUI PHARMA  1H26 Net Profit Rises 0.3% YoY to RMB4.465 Billion; Shares Now Down Over 7%](https://longbridge.com/en/news/296422700.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**